global market overview

2. Welcome
SPW Global Equity
March 2017
For professional investors and authorised intermediaries only
Not for distribution to retail investors

3. 3
For authorised intermediaries only and not for
distribution to retail investors
Sanlam Private Wealth is a trading name of Sanlam Private Investments (UK) Ltd
which is authorised and regulated by the Financial Conduct Authority. Registered in
England and Wales No.2041819. Registered Office: 16 South Park, Sevenoaks, Kent
TN13 1AN.
This presentation is for information purposes and should not be treated as a forecast,
research or advice to buy or sell any particular investment or to adopt any investment
strategy. Any views expressed are based on information received from a variety of sources
which we believe to be reliable, but are not guaranteed as to accuracy or completeness by
Sanlam Private Wealth. Any expressions of opinion are subject to change without notice.
Reproduction of this presentation is not allowed in whole or in part without prior written
agreement from Sanlam Private Wealth. Past performance is not a reliable indicator of
future results. Investing involves risk and the value of investments and the income from
them may fall as well as rise and are not guaranteed. Investors may not get back the
original amount invested.

4. Section 1INVESTMENT PROCESS

5. 5
SPW Global Equity Team
Source: SPW UK
Institutional Funds:
USD 250 million
Global Equity Mandates:
USD 450 million
Team’s Total AUM $700 million

6. 6
SPW Global Equity Products
Source: SPW UK
Active management
High quality focus
Investments based on
risk/reward
Benchmark agnostic
Portfolio: 20-35
holdings
Objective: Produce compound total returns in excess of the MCSI World
Index over the medium to long-term

7. Disciplined investment approach
• Screening process based upon
a range of metrics
• Meetings with company
management and investor
relations
• Utilise external and sell-side
research sources
Generation of
stock ideas
• Rigorous and detailed bottom-
up company analysis
• Focus on the capital structure
of the business
• Look for strong and
sustainable competitive
advantages
• A strong and growing free
cash flow trend over time
Fundamental
analysis
• Active management,
constantly revisiting the thesis
• Understanding of risk-reward
trade-off
• Buy and sell discipline based
on fundamental valuation
• Risk is viewed as a
permanent loss of capital
Portfolio
construction

8. 8
Stock analysis: quantitative screening
process
Bottom-up stock selection with a focus on high quality businesses
Income and cash
flow statement:
High free cash flow
conversion
Attractive gross &
operating margins
Sustainable revenue
growth profile
Balance sheet:
Focus on the capital
structure
Low leverage
Low capital
requirements
High returns on
capital
Business
fundamentals:
Dominant market
position
Sustainable
franchises with
strong management
teams
Clear path for
growth

9. 9
Why a focus on quality?
• High quality equities have historically produced superior
shareholder returns
• Emphasis on low leverage - maintain strong balance sheets
• Focus on high returns on capital and the capital structure
• Preference for attractive gross and operating margins
• Free cash flow growth: Equities that should offer an element of
protection when the market’s valuation is stretched
• Performance is driven by earnings (cash flow) growth rather
than a re-rating of the earnings multiple
• Quality equities invariably provide lower downside risk in
uncertain times
• Valuation approach is not restrictive: strong preference for free
cash flow based methodologies

10. 10
• Our core equity focus remains
squarely on sustainable
structural growth
• We seek to invest in businesses
with:
High returns on capital
Stable margins
Low capital requirements
Minimal debt
Strong cash generation
Dividend growth or the
capacity to sustainably
return cash to shareholders
Focus on the quality
Source: Bloomberg
0
500
1000
1500
2000
2500
3000
A measure of “quality” stocks compared to
general market
S&P 500 Dividend Aristocrats Total Return (GBP)
S&P 500 Total Return (GBP)

11. 11
£5,000 Investment with/without Income
Reinvested
GBP, FTSE All-Share returns

12. Section 2PERFORMANCE

13. 13
Where this fund is acquired through a portfolio management service, additional charges may be applied by the portfolio manager.
The comparison index is the MSCI World Index with net dividends reinvested. Sector is the IA Global.
• C Share Class (as at 28 February2017). Fund launch was 28 February 2014. Fund performance is calculated on a NAV to NAV basis,
net of charges and assumes net income is reinvested. Since investors may be liable to external fees, charges and taxes, the illustrated returns are not
meant to provide a measure of actual return to investors. Class C shares are only available to those investors who have a separate investment
management mandate with the Investment Manager
SPW Global High Quality Fund C Share
performance
since inception in GBP (28 February 2014)
Sources: SPW UK, Bloomberg, MSCI, Morningstar GBP returns since fund inception on 28 February 2014 to 28 February 2017
Current year performance for period ending 28.02.2017
1 Year Since Inception
SPW Global High Quality Fund* 33.7% 73.1%
MSCI World Net Total Return (GBP) 35.9% 56.8%
Relative Return -1.6% 10.4%
Current year performance for period ending 28.02.2017
2014 2015 2016 2017 YTD
Since
Inception
SPW Global High Quality
Fund* 12.5% 12.1% 28.7% 6.7% 73.1%
MSCI World Net TR (GBP) 11.4% 4.8% 28.3% 4.6% 56.8%
Relative Return 0.9% 7.0% 0.3% 1.9% 10.4%

14. 14
SPW Global High Quality Fund C Share relative
performance vs. index and sector average
since inception in GBP (28 February 2014)
Sources: SPW UK, Bloomberg GBP returns since fund inception on 28 February 2014 to 28 February 2017.
Where this fund is acquired through a portfolio management service, additional charges may be applied by the portfolio manager.
The comparison index is the MSCI World Index with net dividends reinvested.
* C Share Class (as at 28 February 2017). Fund launch was 28 February 2014. Fund performance is calculated on a NAV to NAV basis,
net of charges and assumes net income is reinvested. Since investors may be liable to external fees, charges and taxes,
the illustrated returns are not meant to provide a measure of actual return to investors. Class C shares are only available to those investors who have a separate investment management mandate
with the Investment Manager
-10%
-5%
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
55%
60%
65%
70%
75%
80%
Feb-14 May-14 Aug-14 Nov-14 Feb-15 May-15 Aug-15 Nov-15 Feb-16 May-16 Aug-16 Nov-16 Feb-17
SPW Global High Quality Fund (GBP) IA OE Global Total Return (GBP) MSCI World Total Return (GBP)

15. 15
Global Income strategy
since strategy inception in GBP (1 January 2013)
Cumulative performance - 01.01.2013 to 28.02.2017
1 Year 3 Year
Since
Inception
(1.1.2013)
SPW Global Income
Strategy GBP
31.1% 78.9% 113.9%
MSCI World Net Total Return
(GBP)
35.9% 56.9% 95.1%
Where this strategy is acquired through a portfolio management service, additional charges may be applied by the portfolio
manager.
The comparison index is the MSCI World Index with net dividends reinvested.
Sources: SPW UK, Bloomberg GBP returns net of all fees since strategy inception on 1 January 2013 to 28 February 2017

16. 16
Global Equity performance
^ Relative return is based on gross numbers in US dollar terms
**Average 65%/35% between MSCI World Net TR Index (USD) and IA £ Strategic Sector (USD)
Source: Sanlam Asset Management (Ireland), Bloomberg, SPW UK (as at 28 February 2017)
Portfolio 1m 3m 6m 1 year 3 Years
Since
inception
Inception
date YTD
Global Equity Diversified portfolio (USD) Gross 4.08% 8.48% 5.28% 19.84% 33.86% 59.25% 01-Jan-13 7.59%
Global Equity Diversified portfolio (USD) Net 3.94% 8.09% 4.48% 17.79% 26.25% 47.06% 01-Jan-13 7.10%
Relative return^ 1.27% 0.66% -2.32% -1.18% 14.99% 6.80% 2.22%
Global Equity Focussed portfolio (USD) Gross 3.53% 8.69% 3.63% 19.22% 35.47% 57.62% 01-Jan-13 7.55%
Global Equity Focussed portfolio (USD) Net 3.32% 8.16% 2.79% 16.96% 27.14% 44.70% 01-Jan-13 6.94%
Relative return^ 0.74% 0.85% -3.85% -1.68% 16.37% 5.71% 2.18%
Global Equity Income portfolio (USD) Gross 4.26% 10.60% 4.13% 19.53% 38.70% 73.62% 01-Jan-13 8.16%
Global Equity Income portfolio (USD) Net 4.04% 10.21% 3.37% 17.14% 32.76% 62.67% 01-Jan-13 7.74%
Relative return^ 1.45% 2.63% -3.38% -1.43% 19.15% 16.44% 2.76%
MSCI World Net Total Return (USD) 2.77% 7.77% 7.78% 21.26% 16.41% 49.11% 01-Jan-13 5.25%
Global Balanced Portfolio (USD) Net 3.39% 7.11% 4.13% 17.06% 20.98% 22.13% 01-Dec-13 6.02%
Composite benchmark** 1.91% 5.90% 3.33% 12.80% 4.50% 6.44% 01-Dec-13 4.25%
Relative return 1.45% 1.14% 0.77% 3.78% 15.76% 14.74% 1.69%

17. Section 3GLOBAL EQUITY ANALYSIS

18. 18
Top 10 largest portfolio holdings
as at 28 February 2017
Source: SPW UK, Bloomberg
Name Region Sector
Johnson & Johnson United States Health Care
Procter & Gamble United States Consumer Staples
Microsoft United States Information Technology
Oracle United States Information Technology
Alphabet United States Information Technology
Fresenius Medical Care Germany Health Care
Cognizant Technology Solutions United States Information Technology
Moody's United States Financials
Unilever Great Britain Consumer Staples
Medtronic United States Health Care

19. 19
Fund Characteristics
Source: SPW UK, Bloomberg
Fund MSCI World Net Index
Price/earnings (NTM) 18.4x 16.1x
Free cash flow yield 4.6% 7.0%
Return on equity 28.3% 9.6%
Operating margin 24.1% 10.1%
Dividend yield 1.1% 2.6%
Net debt/EBITDA 0.0x 2.9x
Weighted market cap. (US$ bn) 109.3 20.3
>$ 50 billion 64%
$10 - 50 billion 32%
<$ 10 billion 3%
Top 10 concentration 35.9% -
Number of holdings 29 1637
Number of countries 6 23

20. 20
Portfolio and fund attributes
Source: SPW UK, Bloomberg, Trustnet
Global Equity Diversified MSCI World Net Index
Ratios:
Price/earnings (12 months forward) 17.7x 16.1x
Free cash flow yield 4.8% 6.8%
Returns on Capital 62.5% 4.3%
Returns on Equity 31.1% 9.7%
Dividend yield 1.8% 2.7%
Net debt/EBITDA -0.5x 3.0x
Rankings (3 year): Sanlam Global High Quality
Trustnet 3/384
Quartile 1

21. 21
Relative fund weights vs MSCI World Index
Source: SPW UK, Bloomberg, MSCI World ETF (SWDA LN)
Sector and geographic positioning is driven by bottom-up stock selection.
4.1%
-8.3%
5.9%
0.1%
-3.6% -3.4% -3.3%
-2.6%
-1.5%
-1.2%
-10%
-8%
-6%
-4%
-2%
0%
2%
4%
6%
8%
Geographic active positioning
10.1%
13.7%
-7.2%
-12.0%
-11.0%
-4.6%
8.8%
-3.7% -3.5%
-6.4%
-15%
-10%
-5%
0%
5%
10%
15%
20%
Sector active positioning

22. 22
Portfolio activity: 2017
Source: SPW UK
Purchases Additions Disposals Reductions
Yum China Medtronic Amgen Moody’s
Fresenius Unilever NetEase
Philip Morris Pernod Ricard

23. Section 4PORTFOLIO – CASE STUDIES

24. 24
Medtronic
Source: Bloomberg , SPW UK, EvaluateMedTech September 2015
Why we like this name
• With high gross margins and a focus on operational
leverage, we expect operating margins to expand to
historic levels of the 25-30% range
• Strong free cash flow profile providing management
with the ability to invest in R&D and return excess
cash flow to shareholders
• Evaluate are forecasting that Medtronic will compound
its revenue by 9.5% per annum for the period 2014-
2020
• Medtronic’s aiming to generate ~$40 billion in free
cash flow over the next five years, implying an 8%
free cash flow yield over the holding period
Description
Medtronic develops therapeutic and diagnostic
medical products. The company's principal
products include those for bradycardia pacing,
tachyarrhythmia management, atrial fibrillation
management, heart failure management, heart
valve replacement, malignant and non-malignant
pain, and movement disorders. Medtronic's
products are sold worldwide.
31%
18%18%
12%
11%
10%
Cardiac Rhythm &
Heart Failure
Coronary & Structural
Heart
Spinal
Neuromodulation
Diabetes
Surgical
Technologies
Business overview
Evaluate MedTech Sales: Top 20 Companies

25. 25
Baidu
Sources: CNNIC
Description
Baidu is the leading Chinese language
Internet search provider. The Company offers
algorithmic search, enterprise search, news,
MP3, image searches, voice assistance,
online storage, and navigation services. The
business consists of three segments, namely,
search services, transaction services and iQiyi
(online video service).
Business overview
Why we like this stock
• China’s dominant search engine Baidu with over
70% internet search market share
• Internet penetration rates are around 50% in
China, which are well below that of developed
markets like North America (~88%) and Western
Europe (~83%).
• We believe Baidu will be able to leverage its
massive 667 million mobile search monthly
active users (MAU’s) with its advanced
technology to enhance long-term monetization.
• we believe the long-term industry dynamics for
Baidu are positive and that it has a wide moat to
withstand short-term headwinds.

26. 26
MasterCard
Sources: MasterCard, Bloomberg, SPW analysis
Description
MasterCard offers payment processing
services for credit and debit cards, electronic
cash, automated teller machines, and
travellers checks. The company does not
issue credit or cards; rather, it markets the
MasterCard (credit, debit, and prepaid cards)
and Maestro (debit and prepaid cards, mainly
in Europe) brands, provides a transaction
authorisation network and collects fees from
members. The company provides its services
in more than 210 countries and territories, and
its cards are accepted at more than 35 million
locations around the globe.
Why we like this stock
• Well-positioned business exposed to a structural
growth market, with electronic payments set to
materially increase over the coming years
• MasterCard benefits from stable pricing, operational
leverage, minimal capital investment requirements
and an attractive business model.
• MasterCard is a business that operates in a highly
defensible duopolistic market with strong networking
effects.
• MasterCard represents a compelling business model
over the long-term, but a quality business is only as
good as the price you pay.
76% 70% 67% 62%
85%
95% 92%
2010 2011 2012 2013 2014 2015 2016
ROIC

27. 27
Pernod Ricard
Source: Bloomberg , SPW UK
Description
Pernod Ricard is a French listed wines and spirits
company. They produce wines, bitters, whiskies,
liqueurs, cognacs and brandies, as well as white
spirits and rums. The Group is present in all four
major geographical regions of the world, with Asia
being their number one market. They are the main
player in both China and India.
Why we like this name
• Pernod Richard is the market leader in the Asian
premium spirits segment, with a strong footprint in
China and India.
• We believe there is room for operating margin
improvement as the portfolio in China and India are
being rebalanced towards higher margin
international brands.
• We expect top line growth to recover as organic
sales growth starts to stabilise in China and returns
to positive growth over the next two years.
Business overview

28. 28
Moody’s
Sources: SPW UK, Company
Description
Moody's is a credit rating, research, and risk
analysis firm. The company provides credit
ratings and related research, data and
analytical tools, quantitative credit risk
measures, risk scoring software, and credit
portfolio management solutions and securities
pricing software and valuation models.
Business overview
68%
32%
Moody’s Investors
Service (MIS)
Moody’s Analytics
(MA)
Why we like this stock
• Moody’s is widely recognised as operating in an
oligopolistic industry as the world’s second
biggest credit rating agency
• Attractive economic moat through strong industry
characteristics, inelastic pricing and high barriers
to entry.
• An high level of recurring revenue, set to grow in
the mid-single digits providing solid visibility.
• Well positioned to capitalise on the expansion in
debt markets

29. 29
Roche
Source: SPW UK, Bloomberg
Description
Roche develops and manufactures
pharmaceutical and diagnostic products.
The Company produces prescription drugs
in the areas of cardiovascular, infectious,
autoimmune, and respiratory diseases,
dermatology, metabolic disorders, oncology,
transplantation, and the central nervous
system.
Business overview
Why we like this name
• Roche has generated a 12% CAGR in free cash
flow over the past ten years, providing
management with ability to invest in R&D and
return excess cash flow to shareholders
• Revenue are expected to grow in the mid-single
digits over the medium to long-term
• The company has been developing a large
number of biologics through Phase III trials during
the past few years in areas such as oncology,
immunology, haematology and cancer
immunotherapy
77%
23%
Pharmaceuticals
Diagnostics
2015-2025 Cumulative contribution from key Pipeline projects
(risk adjusted) vs. Biosimilar erosion

30. Section 5MARKET AND OUTLOOK

31. 31
Key global uncertainties
1. Donald Trump is having an enormous impact on
financial markets. Business friendly rhetoric, such as
lower tax rates and less regulation, supports the
outlook for equities but, on the other side of the coin,
anti trade comments and expectations for a larger
budget deficit are shaking bonds off their record
valuations. Interesting times indeed
2. “Brexit” worries are well founded, but the pound and
bond yields have already dropped so, until we have a
clearer idea about the outcome of the negotiations with
the EU, much the uncertainty is already in the price.
3. Central bank policy remains accommodative and
while it remains so it will underpin asset prices. The US
is the best performing developed economy and will to
continue to incrementally raise interest rates but even
after several hikes policy would still be accommodative
by historical standards.

32. 32
The Trump Factor
Investors too excited about policy evolution?
Source: Bloomberg / Cornerstone Macro
15
25
35
45
55
Nov 14 Feb 15 May 15 Aug 15 Nov 15 Feb 16 May 16 Aug 16 Nov 16
AAII US Investor Sentiment Bullish Readings
Investors most bullish they
have been for 2 years

33. 33
Sector rotation continues to be volatile
Source: Bloomberg

34. 34
FTSE All-Share Index intra-year declines vs.
calendar-year returns
Despite average intra-year drops of 15.8% (median 12.6%), annual
returns are positive in 22 of 31 years

35. 35
Top Heavy Market

36. 36
• Pricing power and returns on capital crucial in
deflationary world
• Some value apparent in segments of Health Care
• Pockets of value in certain European sectors
• Global “quality” businesses with strong cash flow and
balance sheets still relatively attractive
• Be prepared to actively manage positions
Strategy for 2017

37. Section 6Team

38. 38
Hannah Peters
Investment Operations
Analyst
Global Equity Team
Louis Jamieson
Global Equity Analyst
Matthew Brittain
Investment Analyst
Niel Laubscher
Global Equity Analyst
William Ball
Senior Equity Analyst
Pieter Fourie
Head of Global Equities
Nicholas Bell
Portfolio Manager
Head of Global Clients

39. 39
SPW’s Investment Team
As at January 2017
Investment Operations
Analyst
Hannah Peters
Head of Fixed Income
Craig Veysey
Head of Global Equities
Pieter Fourie
Senior Equity
Analyst
Duncan Burden
Chief Investment Officer
Philip
Smeaton
Investment Analyst
Matthew Brittain
Global Equity Analyst
Louis Jamieson
Global Equity Analyst
Niel Laubscher
Senior Equity
Analyst
William Ball
Global Portfolio Manager
Nicholas Bell

40. 40
Pieter Fourie CA (SA), CFA
Head of Global Equites and Lead Portfolio Manager
As Head of Global Equities, Pieter Fourie is the Lead Portfolio Manager for the SPW
Global High Quality Equity and the Clime International Equity funds having joined the
firm in mid 2012. His responsibilities include the design, management and
implementation of our global equity client offering including segregated mandates for
high net worth individuals. Pieter oversees a team of six analysts focusing on global and
UK equities across multiple industries. Current assets under management managed by
the investment team in direct global and UK equity mandates is $600mn within a larger
client base of £2.2bn.
Pieter received an honours degree in accounting from the University of Stellenbosch in
1994 and became a Chartered Accountant with Ernst & Young a few years later. He
joined the Stonehage group in 1999 and successfully managed a global equity fund for
seven years and global equity mandates for high net worth individuals and institutions
whilst serving on various boards within the group across multiple jurisdictions.
Team biographies – global equities

41. 41
Team biographies – global equities
William Ball
Senior Equity Analyst and Deputy Portfolio Manager
William Ball is a Senior Equity Analyst, who has been the Deputy Portfolio Manager of
the SPW Global High Quality Fund and co-portfolio manager of the Clime International
Equity Fund since inception. In conjunction with the Head of Global Equities, he is
responsible for global equity research and managing the high net worth global equity
mandates and the global equity offerings.
William has nearly 11 years of investment experience and a track record of investing in
equities. Prior to joining Sanlam in 2009, he worked at Brown Shipley managing private
client portfolios before moving to Merrill Lynch where William was involved with quasi-
intuitional mandates. When he joined Sanlam, he was initially responsible for research
and managing client portfolios before focusing solely on equity analysis in mid 2012.
William has a degree in business administration from Northumbria University, holds the
IMC and has passed the CFA level one examination.

42. 42
Team biographies – global equities
Louis Jamieson
Global Equity Analyst
Louis joined SPW in November 2014 working with the Head of Global Equities as a
Global Equity Analyst. He graduated with a first class honours degree in Mathematics
from Trinity College Dublin before going on to complete an MSc in Mathematical Finance
at Imperial College London. He is currently studying towards becoming a Chartered
Financial Analyst having passed his CFA Level 2 in June 2016.
Niel Laubscher CA(SA)
Global Equity Analyst
Niel joined SPW in 2015 working with the Head of Global Equities as a Global Equity
Analyst. Prior to joining SPW UK he worked as a junior investment analyst as part of the
Investment team in South Africa under the Director of Investments.
Niel holds a Bachelor of Accounting (2010) and a Bachelor of Accounting with Honours
(2011) from Stellenbosch University. He completed his three year articles in 2014 at
PricewaterhouseCoopers and became a Chartered Accountant in 2015. He is currently
studying towards becoming a Chartered Financial Analyst having passed CFA Level 2 in
2016.

43. 43
Team biographies – global equities
Matthew Brittain
Investment Analyst
Matthew joined the SPW UK investment team in London in 2015 as an analyst. He
graduated from the University of Pretoria in South Africa with an Honours degree in
Economics in 2012 and subsequently joined Sanlam Private Wealth as a Junior Portfolio
Manager in the Johannesburg office. Matthew has also passed the three levels of the
Chartered Financial Analyst qualification and has the distinction of having won an
Olympic Gold medal in rowing for his native South Africa at the London games in 2012.
Nicholas Bell
Portfolio Manager – Global Clients
Before joining Sanlam Private Wealth in the UK, Nicholas worked as a portfolio manager
at RMB Private Bank in South Africa for 4 years where he was a member of the
investment team and covered various shares in the industrial and financials space. He
then became a Portfolio Manager in Sanlam Private Wealth, Johannesburg, for 6 years
where he was responsible for managing high net worth individual’s portfolios.
Nick has over ten years of industry experience. He holds a Bachelor of Commerce
degree from the University of Stellenbosch and a Bachelor of Commerce (Honours)
degree from the University of Cape Town. He has also completed levels 1 & 2 of the
CFA exams and recently passed his IMC exam.

44. 44
Important information
• Investing involves risk. The value of investments, and the income from them, may fall
as well as rise. Investors may not get back the original amount invested. Further
information will be provided by Sanlam Private Wealth.
• The value of fixed interest securities is affected by the risk of default by the issuer and
where an issuer does default you may lose some or all of your capital investments in
higher yielding bonds issued by borrowers with lower credit ratings may result in a
greater risk of default and have a negative impact on income and capital value.
• The value of investments in overseas securities may rise and fall in sterling terms
purely as a result of exchange rate fluctuations.
• The Sanlam Group does not accept any liability for any claims, loss or damage, as a
result of reliance placed on the information in this presentation, or in respect of the
use of this presentation, in the form provided, or otherwise.
• Sanlam Private Wealth is a trading name of Sanlam Private Investments (UK) Ltd and
is authorised and regulated by the Financial Conduct Authority

45. 45
Contact details
BATH 5 Miles’s Buildings, George Street, Bath BA1 2QS 01225 460 010
HARROGATE High Point House, 7 Victoria Avenue, Harrogate, North Yorkshire HG1 1EQ 01423 701800
KIRKBY LONSDALE Bank House, 55 Main Street, Kirkby Lonsdale, Cumbria LA6 2AH 015242 72941
LONDON Monument Place 24 Monument Street London EC3R 8AJ10 020 7280 8700
MARLOW Wall Terrace, 44-46 Chapel Street, Marlow, Buckinghamshire SL7 1DD 01628 473298
NEWCASTLE 11 West Road, Ponteland, Newcastle upon Tyne NE20 9SU 0191 300 9242
SEVENOAKS 16 South Park, Sevenoaks, Kent TN13 1AN 01732 740 700
(Registered office)
TEESSIDE Cedar House, Princeton Drive, Teesdale Business Park, Stockton-on-Tees TS17 6AJ 01642 931200
www.sanlamprivatewealth.co.uk

46. Thank you